| 679 |
Meconium
|
|
None
|
| 680 |
Cholesterol
|
-
Cholesterol, CAS-RN: 57-88-5, DTXSID3022401
|
None
|
| 681 |
Prototypical stressor
|
|
211: Handbook development AOP
|
| 682 |
WIN18,466
|
|
None
|
| 683 |
(~13~C,~15~N_2_)Cyanamide
|
-
(~13~C,~15~N_2_)Cyanamide, CAS-RN: 87009-57-2, DTXSID90745933
|
None
|
| 684 |
Molinate
|
-
Molinate, CAS-RN: 2212-67-1, DTXSID6024206
|
None
|
| 685 |
Pebulate
|
-
Pebulate, CAS-RN: 1114-71-2, DTXSID8021199
|
None
|
| 686 |
Vernolate
|
-
Vernolate, CAS-RN: 1929-77-7, DTXSID7024376
|
None
|
| 687 |
Butylate
|
-
Butylate, CAS-RN: 2008-41-5, DTXSID7023936
|
None
|
| 688 |
Tri-allate
|
-
Tri-allate, CAS-RN: 2303-17-5, DTXSID5024344
|
None
|
| 689 |
Cycloate
|
-
Cycloate, CAS-RN: 1134-23-2, DTXSID6032356
|
None
|
| 690 |
Itraconazole
|
-
Itraconazole, CAS-RN: 84625-61-6, DTXSID3023180
|
None
|
| 691 |
Candesartan cilexetil
|
-
Candesartan cilexetil, CAS-RN: 145040-37-5, DTXSID5020239
|
None
|
| 692 |
Montelukast
|
-
Montelukast, CAS-RN: 158966-92-8, DTXSID9023334
|
None
|
| 693 |
Repaglinide
|
-
Repaglinide, CAS-RN: 135062-02-1, DTXSID3023552
|
None
|
| 694 |
Liarozole
|
-
Liarozole, CAS-RN: 115575-11-6, DTXSID9048277
|
None
|
| 695 |
(R)-Talarozole
|
-
(R)-Talarozole, CAS-RN: 870093-23-5, DTXSID50236074
|
None
|
| 696 |
Stressor:282 Ketoconazole
|
|
None
|
| 697 |
all-trans-Retinoic acid
|
-
all-trans-Retinoic acid, CAS-RN: 302-79-4, DTXSID7021239
|
None
|
| 698 |
Diethylhexyl phthalate
|
|
431: Increased tumor necrosis factor (TNF) leading to increased risk of gestational diabetes mellitus (GDM)
|
| 699 |
Influenza Virus
|
|
506: Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
|
| 700 |
Escitalopram
|
-
Escitalopram, CAS-RN: 128196-01-0, DTXSID8048440
|
None
|
| 701 |
Astemizole
|
-
Astemizole, CAS-RN: 68844-77-9, DTXSID9020110
|
None
|
| 702 |
Probucol
|
-
Probucol, CAS-RN: 23288-49-5, DTXSID2045440
|
None
|
| 703 |
Quinidine
|
-
Quinidine, CAS-RN: 56-54-2, DTXSID4023549
|
None
|